[Proximal tubular impairment (Fanconi syndrome)].
Deschênes
G
G
Assistance publique-Hôpitaux de Paris, Paris, France. georges.deschenes@trs.aphp.fr
D015090:25-Hydroxyvitamin D3 1-alpha-Hydroxylase / Q000235:genetics / Q000502:physiology; D017920:Antiporters / Q000235:genetics; D002648:Child; D003554:Cystinosis / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology; D004252:DNA Mutational Analysis; D003937:Diagnosis, Differential; D005198:Fanconi Syndrome / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology*; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000235:genetics / Q000502:physiology; D006801:Humans; D007671:Kidney Concentrating Ability / Q000235:genetics / Q000502:physiology; D007687:Kidney Tubules, Proximal / Q000503:physiopathology; D010641:Phenotype; D010710:Phosphates / Q000097:blood; D010744:Phosphoric Monoester Hydrolases / Q000235:genetics / Q000502:physiology; D015398:Signal Transduction / Q000235:genetics
D017920:Antiporters; D010710:Phosphates; C114260:hydrogen-chloride symporter; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23; D015090:25-Hydroxyvitamin D3 1-alpha-Hydroxylase; D010744:Phosphoric Monoester Hydrolases; C075695:OCRL protein, human